Global HER2 Antibody Drug Conjugate Market Research Report 2025

Publication ID:

PB503250378

Publication Date:

March 3, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The global market for HER2 Antibody Drug Conjugate was valued at US$ 6231 million in the year 2024 and is projected to reach a revised size of US$ 18480 million by 2031, growing at a CAGR of 16.8% during the forecast period.
HER2 antibody-drug conjugate (ADC) is an innovative, targeted anticancer therapy that combines monoclonal antibodies specific to human epidermal growth factor receptor 2 (HER2) with potent cytotoxic drugs via ligons. This antibody is responsible for recognizing and binding to the surface of HER2-positive cancer cells, delivering the drug precisely to the tumor cells, and then releasing the drug inside the cancer cells to induce cell death, thus effectively inhibiting tumor growth, while reducing damage to normal cells, improving treatment effectiveness and reducing side effects. It shows a good application prospect in the treatment of HER2-positive cancers such as breast cancer and gastric cancer.
North American market for HER2 Antibody Drug Conjugate is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for HER2 Antibody Drug Conjugate is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of HER2 Antibody Drug Conjugate include Roche, Daiichi Sankyo, RemeGen, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for HER2 Antibody Drug Conjugate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HER2 Antibody Drug Conjugate.
The HER2 Antibody Drug Conjugate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global HER2 Antibody Drug Conjugate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the HER2 Antibody Drug Conjugate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Roche
Daiichi Sankyo
RemeGen
Segment by Type
100mg/ bottle
440mg/ bottle
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of HER2 Antibody Drug Conjugate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of HER2 Antibody Drug Conjugate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 HER2 Antibody Drug Conjugate Market Overview
1.1 Product Definition
1.2 HER2 Antibody Drug Conjugate by Type
1.2.1 Global HER2 Antibody Drug Conjugate Market Value Comparison by Type (2024 VS 2031)
1.2.2 100mg/ bottle
1.2.3 440mg/ bottle
1.3 HER2 Antibody Drug Conjugate by Application
1.3.1 Global HER2 Antibody Drug Conjugate Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global HER2 Antibody Drug Conjugate Market Size Estimates and Forecasts
1.4.1 Global HER2 Antibody Drug Conjugate Revenue 2020-2031
1.4.2 Global HER2 Antibody Drug Conjugate Sales 2020-2031
1.4.3 Global HER2 Antibody Drug Conjugate Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 HER2 Antibody Drug Conjugate Market Competition by Manufacturers
2.1 Global HER2 Antibody Drug Conjugate Sales Market Share by Manufacturers (2020-2025)
2.2 Global HER2 Antibody Drug Conjugate Revenue Market Share by Manufacturers (2020-2025)
2.3 Global HER2 Antibody Drug Conjugate Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of HER2 Antibody Drug Conjugate, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of HER2 Antibody Drug Conjugate, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of HER2 Antibody Drug Conjugate, Product Type & Application
2.7 Global Key Manufacturers of HER2 Antibody Drug Conjugate, Date of Enter into This Industry
2.8 Global HER2 Antibody Drug Conjugate Market Competitive Situation and Trends
2.8.1 Global HER2 Antibody Drug Conjugate Market Concentration Rate
2.8.2 The Global 5 and 10 Largest HER2 Antibody Drug Conjugate Players Market Share by Revenue
2.8.3 Global HER2 Antibody Drug Conjugate Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global HER2 Antibody Drug Conjugate Market Scenario by Region
3.1 Global HER2 Antibody Drug Conjugate Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global HER2 Antibody Drug Conjugate Sales by Region: 2020-2031
3.2.1 Global HER2 Antibody Drug Conjugate Sales by Region: 2020-2025
3.2.2 Global HER2 Antibody Drug Conjugate Sales by Region: 2026-2031
3.3 Global HER2 Antibody Drug Conjugate Revenue by Region: 2020-2031
3.3.1 Global HER2 Antibody Drug Conjugate Revenue by Region: 2020-2025
3.3.2 Global HER2 Antibody Drug Conjugate Revenue by Region: 2026-2031
3.4 North America HER2 Antibody Drug Conjugate Market Facts & Figures by Country
3.4.1 North America HER2 Antibody Drug Conjugate Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America HER2 Antibody Drug Conjugate Sales by Country (2020-2031)
3.4.3 North America HER2 Antibody Drug Conjugate Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe HER2 Antibody Drug Conjugate Market Facts & Figures by Country
3.5.1 Europe HER2 Antibody Drug Conjugate Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe HER2 Antibody Drug Conjugate Sales by Country (2020-2031)
3.5.3 Europe HER2 Antibody Drug Conjugate Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific HER2 Antibody Drug Conjugate Market Facts & Figures by Region
3.6.1 Asia Pacific HER2 Antibody Drug Conjugate Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific HER2 Antibody Drug Conjugate Sales by Region (2020-2031)
3.6.3 Asia Pacific HER2 Antibody Drug Conjugate Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America HER2 Antibody Drug Conjugate Market Facts & Figures by Country
3.7.1 Latin America HER2 Antibody Drug Conjugate Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America HER2 Antibody Drug Conjugate Sales by Country (2020-2031)
3.7.3 Latin America HER2 Antibody Drug Conjugate Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa HER2 Antibody Drug Conjugate Market Facts & Figures by Country
3.8.1 Middle East and Africa HER2 Antibody Drug Conjugate Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa HER2 Antibody Drug Conjugate Sales by Country (2020-2031)
3.8.3 Middle East and Africa HER2 Antibody Drug Conjugate Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global HER2 Antibody Drug Conjugate Sales by Type (2020-2031)
4.1.1 Global HER2 Antibody Drug Conjugate Sales by Type (2020-2025)
4.1.2 Global HER2 Antibody Drug Conjugate Sales by Type (2026-2031)
4.1.3 Global HER2 Antibody Drug Conjugate Sales Market Share by Type (2020-2031)
4.2 Global HER2 Antibody Drug Conjugate Revenue by Type (2020-2031)
4.2.1 Global HER2 Antibody Drug Conjugate Revenue by Type (2020-2025)
4.2.2 Global HER2 Antibody Drug Conjugate Revenue by Type (2026-2031)
4.2.3 Global HER2 Antibody Drug Conjugate Revenue Market Share by Type (2020-2031)
4.3 Global HER2 Antibody Drug Conjugate Price by Type (2020-2031)
5 Segment by Application
5.1 Global HER2 Antibody Drug Conjugate Sales by Application (2020-2031)
5.1.1 Global HER2 Antibody Drug Conjugate Sales by Application (2020-2025)
5.1.2 Global HER2 Antibody Drug Conjugate Sales by Application (2026-2031)
5.1.3 Global HER2 Antibody Drug Conjugate Sales Market Share by Application (2020-2031)
5.2 Global HER2 Antibody Drug Conjugate Revenue by Application (2020-2031)
5.2.1 Global HER2 Antibody Drug Conjugate Revenue by Application (2020-2025)
5.2.2 Global HER2 Antibody Drug Conjugate Revenue by Application (2026-2031)
5.2.3 Global HER2 Antibody Drug Conjugate Revenue Market Share by Application (2020-2031)
5.3 Global HER2 Antibody Drug Conjugate Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Company Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche HER2 Antibody Drug Conjugate Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Roche HER2 Antibody Drug Conjugate Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Daiichi Sankyo
6.2.1 Daiichi Sankyo Company Information
6.2.2 Daiichi Sankyo Description and Business Overview
6.2.3 Daiichi Sankyo HER2 Antibody Drug Conjugate Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Daiichi Sankyo HER2 Antibody Drug Conjugate Product Portfolio
6.2.5 Daiichi Sankyo Recent Developments/Updates
6.3 RemeGen
6.3.1 RemeGen Company Information
6.3.2 RemeGen Description and Business Overview
6.3.3 RemeGen HER2 Antibody Drug Conjugate Sales, Revenue and Gross Margin (2020-2025)
6.3.4 RemeGen HER2 Antibody Drug Conjugate Product Portfolio
6.3.5 RemeGen Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 HER2 Antibody Drug Conjugate Industry Chain Analysis
7.2 HER2 Antibody Drug Conjugate Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 HER2 Antibody Drug Conjugate Production Mode & Process Analysis
7.4 HER2 Antibody Drug Conjugate Sales and Marketing
7.4.1 HER2 Antibody Drug Conjugate Sales Channels
7.4.2 HER2 Antibody Drug Conjugate Distributors
7.5 HER2 Antibody Drug Conjugate Customer Analysis
8 HER2 Antibody Drug Conjugate Market Dynamics
8.1 HER2 Antibody Drug Conjugate Industry Trends
8.2 HER2 Antibody Drug Conjugate Market Drivers
8.3 HER2 Antibody Drug Conjugate Market Challenges
8.4 HER2 Antibody Drug Conjugate Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Roche
Daiichi Sankyo
RemeGen

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂